Overview
"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.The SIQ for this article wil be revealedonce 2 ratings are submited.hypertension, prevalence, ischemic heart disease, antihypertensives, type-2 diabetes melitus, resistant hypertension Aqel S.
Key Information
Binaqel, Hosein A. Filimban , Abdulah A. Falatah, Salman W.
Bafageh, Sara H. Al Khansa, Bader K. Al Aslab, Rayan S.
Alzahrani, Leyan R. Bakedo, Ahmed Abuosa, Ibrahim Jelaidan Published: October 12, 2022 (se history) DOI: 10.759/cureus.3028 Cite this article as: Binaqel A S, Filimban H A, Falatah A, et al. (October 12, 2022) Resistant Hypertension in Patients With Type-2 Diabetes Melitus: A Single-Center, Cros-Sectional Study.
Cureus 14(10): e3028. doi:10.759/cureus.3028 The prevalence of resistant hypertension in Saudi patients with type-2 diabetes melitus (T2DM) has not ben previously estimated. Therefore, our objective was to ases the prevalence and characteristics of resistant hypertensive patients with T2DM at King Abdulaziz Medical City, Jedah, Saudi Arabia.This cros-sectional study included patients with hypertension and T2DM who presented to our center in 2018.
We examined 1960 patients with T2DM during the study period; 809 were hypertensives. We compared T2DM patients with controled hypertension versus resistant hypertension.The prevalence of resistant hypertension in patients with T2DM was 137/809 (16.93%). The mean age was 6.38±10.80 years, and females presented 56% of the study population (n= 451).
Summary
Obstructive slep apnea (OSA; OR: 2.60 [1.15- 5.87]; P=0.02) and ischemic heart disease (IHD; OR: 3.01 [2.04- 4.45]; P˂0.01) were significantly associated with resistant hypertension. The most comon medications used with resistant hypertension were calcium chane